课题基金 / 基金详情

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
内分泌干​​扰对衰老和阿尔茨海默病的性别特异性影响
批准号:
10414010
负责人:
KEJAL KANTARCI
金额:
$153.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2024-05-31

项目摘要

项目成果

KEJAL KANTARCI的其他基金

相似基金

相关文献

中文摘要
翻译
Michelle M. Mielke博士
英文摘要
OVERALL: SUMMARY/ABSTRACT Michelle M. Mielke, Ph.D. Aging-associated physical and cognitive decline and Alzheimer's disease (AD) are conditions that affect men and women differently across their lifespan. There are important sex and gender differences for these conditions, including risk factors, manifestations, response to treatments, morbidity, and mortality. The overarching theme of the Mayo Clinic Specialized Center of Research Excellence (SCORE) on Sex Differences is to investigate how abrupt loss of ovarian hormones, caused by bilateral salpingo-oophorectomy (BSO) prior to natural menopause, affects overall aging, physical and cognitive function, and risk for AD pathophysiology. Given the large number of aging women with a history of premenopausal BSO, there is an urgent need to understand the long-term physical and cognitive outcomes. In addition, we need new evidence to empower women considering prophylactic BSO to make more informed decisions in the future. The central hypothesis of our SCORE renewal is that the abrupt endocrine disruption caused by premenopausal BSO will accelerate pathological aging processes that manifest as reductions in physical and cognitive function and in AD pathophysiology. This hypothesis will be tested through three inter-related translational projects, which are supported by three inter-dependent Cores. Our interdisciplinary translational approach using both humans (Projects 1 and 2) and mice (Project 3) provides the foundation to: 1) establish the effects of abrupt endocrine disruption in women, 2) develop a more complete understanding of the biological mechanisms involved, 3) devise a targeted approach to identify and mitigate the adverse outcomes, 4) design future studies to mechanistically test whether targeting senescent cells mitigates the effects of accelerated aging in these women, and 5) empower women considering prophylactic BSO to make more informed decisions. Our rigorous approach is supported by an experienced leadership team through the Leadership Administrative Core, by a Resource Support Core - Clinical that will provide financial and operational efficiency for participant recruitment, and by a Career Enhancement Core that will provide career enrichment, leadership training, and funds to support ancillary studies of the main projects. These resources will stimulate new interest in sex differences and women's health. The Mayo Clinic SCORE will serve as a vital hub for education and dissemination of innovative sex-based translational research methods, results, and best practices. Our integrated approach for research, training, and education is consistent with the goals of the SCORE on Sex Differences RFA, and assures continuing research in areas of women's health and sex differences by training the work force of the future.
期刊论文(167)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pbio.1002484
发表时间: 2016-06
期刊: PLoS biology
影响因子: 9.8
作者: [Weissgerber TL, Garovic VD, Savic M, Winham SJ, Milic NM]
通讯作者: Milic NM
DOI: 10.1038/s41533-022-00317-4
发表时间: 2022-11-15
期刊: NPJ PRIMARY CARE RESPIRATORY MEDICINE
影响因子: 3.1
作者: [Nguyen, Trinh T., Smith, Carin Y., Rocca, Liliana Gazzuola, Rocca, Walter A., Vassallo, Robert, Scrodin, Megan M. Dulohery]
通讯作者: Scrodin, Megan M. Dulohery
DOI: 10.1093/cvr/cvab063
发表时间: 2022-02-21
期刊: Cardiovascular research
影响因子: 10.8
作者: [Vallabhajosyula S, Verghese D, Desai VK, Sundaragiri PR, Miller VM]
通讯作者: Miller VM
DOI: 10.1016/j.maturitas.2023.01.012
发表时间: 2023-02
期刊: Maturitas
影响因子: 4.9
作者: [W. Rocca;L. Gazzuola Rocca;Carin Y. Smith;Ekta Kapoor;S. Faubion;E. Stewart]
通讯作者: W. Rocca;L. Gazzuola Rocca;Carin Y. Smith;Ekta Kapoor;S. Faubion;E. Stewart
共 104 条
    Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
    • 批准号:
      10307050
    • 项目类别:
    • 资助金额:
      $72.13万
    • 财政年份:
      2021
    • 负责人:
      KEJAL KANTARCI
    • 依托单位:
    Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
    • 批准号:
      10712212
    • 项目类别:
    • 资助金额:
      $44.98万
    • 财政年份:
      2021
    • 负责人:
      KEJAL KANTARCI
    • 依托单位:
    Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
    • 批准号:
      10445068
    • 项目类别:
    • 资助金额:
      $64.42万
    • 财政年份:
      2021
    • 负责人:
      KEJAL KANTARCI
    • 依托单位:
    NAPS2 Neuroimaging Core
    • 批准号:
      10674049
    • 项目类别:
    • 资助金额:
      $53.77万
    • 财政年份:
      2021
    • 负责人:
      KEJAL KANTARCI
    • 依托单位:
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
    • 批准号:
      82505677
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.00万元
    • 批准年份:
      2025
    • 负责人:
      吕雨霏
    • 依托单位:
    麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
    • 批准号:
      82574874
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2025
    • 负责人:
      刘天华
    • 依托单位:
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: